Home › Funds › Patient Square Capital LP › DFTX

Patient Square Capital LP position in DFTX

DEFINIUM THERAPEUTICS INC · Health Care

Patient Square Capital LP reported holding 385,000 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$14.7M, representing 2.34% of its reported portfolio and ranking #10 among its reported holdings. Patient Square Capital LP has disclosed DFTX holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)385.00K sh
Reported value held$14.65M
Portfolio Weight2.34%
First reportedQ1 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's DFTX position evolved

Patient Square Capital LP first disclosed a stake in DFTX in Q1 2026 at 331,000 shares (US$6.3M). The position peaked in Q3 2026 at 385,000 shares, worth US$14.7M. Across 2 filings, Patient Square Capital LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 385,000 shares valued at US$14.7M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 331.00K $6.26M New
Q3 2026 385.00K $14.65M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DFTX and 13F data

DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 158 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DFTX

All DFTX fund holders →

FAQ

How long has Patient Square Capital LP held DFTX?

Patient Square Capital LP has disclosed DFTX holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

What is Patient Square Capital LP's current position in DFTX?

As of Q3 2026, Patient Square Capital LP holds 385.00K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $14.65M, representing 2.34% of its reported portfolio and ranking #10.

Has Patient Square Capital LP been buying or selling DFTX?

In the latest 13F filing (Q3 2026), Patient Square Capital LP newly opened its position in DFTX. The position peaked in Q3 2026 at 385.00K shares.

Which other funds hold DFTX?

Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 158 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.